Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis
-
* Corresponding author: Jan Bouchal jan.bouchal@gmail.com
BMC Cancer 2007, 7:55 doi:10.1186/1471-2407-7-55
Accesses
- Last 30 days: 120 accesses
- Last 365 days: 1336 accesses
- All time: 9543 accesses
Cited by
BioMed Central: 6 citations
|
Research article
Manju Mamtani, Hemant Kulkarni BMC Research Notes 2012, 5:25 (12 January 2012) |
|
Research
Bimodal gene expression patterns in breast cancer Marina Bessarabova, Eugene Kirillov, Weiwei Shi, Andrej Bugrim, Yuri Nikolsky, Tatiana Nikolskaya BMC Genomics 2010, 11(Suppl 1):S8 (10 February 2010) |
|
Research article
Increased levels of active c-Src distinguish invasive from in situ lobular lesions Donghui Zou, Han-Seung Yoon, Ahmad Anjomshoaa, David Perez, Ryuji Fukuzawa, Parry Guilford, Bostjan Humar Breast Cancer Research 2009, 11:R45 (7 July 2009) |
|
Research article
Tim Eiseler, Heike Döppler, Irene K Yan, Steve Goodison, Peter Storz Breast Cancer Research 2009, 11:R13 (25 February 2009) Protein kinase D1 is identified as a marker for invasive breast cancer, while loss of PKD1 expression may increase the malignant potential of breast cancer cells, suggesting re-expression of PKD1 as a possible therapeutic strategy.
|
|
Research article
A resampling-based meta-analysis for detection of differential gene expression in breast cancer Bala Gur-Dedeoglu, Ozlen Konu, Serkan Kir, Ahmet Ozturk, Betul Bozkurt, Gulusan Ergul, Isik G Yulug BMC Cancer 2008, 8:396 (30 December 2008) |
|
Research article
A functional Notch–survivin gene signature in basal breast cancer Connie W Lee, Karl Simin, Qin Liu, Janet Plescia, Minakshi Guha, Ashraf Khan, Chung-Cheng Hsieh, Dario C Altieri Breast Cancer Research 2008, 10:R97 (24 November 2008) Notch-1-survivin functional gene signature validation as a basal breast cancer hallmark suggests novel roles for Notch and survivin antagonists as molecular therapies against this recurrence-prone disease type.
|